Studies have reported that in some nervous system diseases, such as cerebral ischemia and cortical and spinal cord injuries, specific interventional measures to promote axon regeneration can be invalidated using LY294002, which inhibits the PI3K/AKT pathway [55–57]. This evidence concerns the gene AKT1 and brain ischemia.